Skip to Content

Autopen Injector

Health Condition

Core Innovation

Login Account

English

Autopen Injector

Health Condition

Core Innovation

Login Account

English

Folder: Products

Autopen Injector

Health Condition

Core Innovation

Login Account

Tablets › Chest Congestion Relief Tablets 400 mg Guaifensein 60 Count

Chest-Congestion-Relief-Tablets-400-mg-Guaifensein-by-Rugby-NDC-00536-1311-08_512x (1).webp

Image 1 of 1

Chest-Congestion-Relief-Tablets-400-mg-Guaifensein-by-Rugby-NDC-00536-1311-08_512x (1).webp

Chest-Congestion-Relief-Tablets-400-mg-Guaifensein-by-Rugby-NDC-00536-1311-08_512x (1).webp

Chest Congestion Relief Tablets 400 mg Guaifensein 60 Count

$100.00

Chest Congestion Relief Tablets 400 mg Guaifenesin 60 Count

Chest Congestion Relief Tablets 400 mg Guaifenesin 60 Count

We are working

on discovering

New Vaccines

Breakthrough in Medicine Production

Breakthrough In Sustainable Pharmaceutical Packaging

Sustainable plastics are alternative materials and circular systems designed to lower carbon emmisions, reduce fossil-fuel dependence and minimize environmental waste compared to conventional virgin plastics.

Sustainable polythene bags are often referred to as eco-friendly are designed to mitigate the environmental impact of traditional, single-use high-density and low-density polyethylene (HDPE/LDPE) plastics. Conventional plastic bags take hundreds of years to break down and decompose into microplastics, contaminating marine ecosystems, soil, and wildlife food chains.

We are at the forefront of New Medicines production by our extensive research targeted towards new medicines discovery and delivery.
Our Production line is very robust we have large scale production platform targeted towards new vials and Pharmaceutical plastics production.

Investors FAQS

To contact us by mail, write: Attn: Investor Relations
KennethPharmaceuticals Inc USA
Illinois Chicago, New Jersey NY,
Kenneth Pharmaceuticals would hold annual Meetings once in a year.
You may contact a licensed stockbroker to purchase shares or Kenneth Pharmaceuticals Shareowner Services administers the Shareowner Services Plus Plan, which allows registered shareholders to purchase additional shares of Kenneth Pharmaceuticals common stock through the automatic investment of dividends.

The plan also allows registered shareholders and new investors to purchase shares with cash payments, either by check or automatic deductions from checking or savings accounts. The minimum initial investment for new investors is $1,000. Subsequent investments must be at least $50. The maximum cash investment during any calendar year is $150,000.

Please direct inquiries to:

1835 W. Jefferson Avenue Naperville , Illinois, 60540 United States
Six Santa Fe Way Cranbury , New Jersey, 08512 United States
13799 Monte Vista Avenue Chino, California, 91708 United States
401-B Parker Drive N/A Austin, Texas, 78728 United States
Parc de Chanteloup 2000 RD N°57 77250 Moissy Cramayel France
Ettenseweg 40 4706 PB Roosendaal Netherlands
DC2, Victoria Park 1-5 Claudius Way Wellingborough NN8 2DH United Kingdom
No.1 Rujiadian Road Lianshi Town Nanxun District Huzhou 313013 Zhejiang Sheng China
Staakener Str. 53 - 63 13581 Berlin Germany
201-27, Roppou-cho, Inage-ku, 千葉市, Chiba, 263-0004 Japan
www.shareowneronline.com

Kenneth Foundation is dedicated to strengthening communities by magnifying the impact of our team's generosity and providing critical aid where it is needed most. Through our corporate giving programs, we match eligible employee donations to amplify their personal charitable impact.”

Mission Statement: The official mission of Kenneth Foundation is straightforward and ambitious to enhance quality of life by promoting early childhood literacy and supporting research to cure chronic diseases.

Our vision: Kenneth Pharmaceuticals Inc. is a Sustainable Pharmaceutical Company with 2030 Strategic Growth Plan. We aspire to build a State-of-the-art, and world-class pharmaceutical research facilities capable of securing a healthier, more prosperous life for current and future generations through the development of New Medicines and Therapeutics. Our Organizations Goals is to:

Empower Innovative Talent: A highly educated, diverse workforce capable of collaborating globally on an equal footing, driving scientific breakthroughs, and building a thriving business in a highly competitive global market.
An Ethical and Inclusive Corporate Culture: A corporate society based on integrity, justice, and benevolence. One that safeguards employee well-being, protects core values, maintains workplace security, and ensures equal opportunities for professional growth for all team members.
Global Health Partnerships: A company that embraces diverse cultures and perspectives, actively playing a leading role in global healthcare partnerships to advance sustainable medicines development and expand access to life-saving treatments.
Sustainable and Responsible Operations: An administrative and manufacturing research Hub capable of maintaining strict harmony between environmental stewardship, regulatory compliance, and economic growth.
A High-Performance Economic Engine: A competitive, innovative commercial system capable of sustaining robust business growth, delivering shareholder value, and funding the next generation of healthcare solutions.

Kennethpharma@outlook.com

CALL US: +1(240)8542566, +1(240)940 8778

ADDRESS: 2419 E 77TH Illinois Chicago USA.

Social media

Public Company: $4.5 Trillion

Core value: Wealth and Sustainability.

(c)2026 Kenneth Pharmaceutical Inc, All right reserved.

No Part of this website may be reproduced, distributed or transmitted in any way without prior notice.

Motto: Science meets Sustainability.

Newsletter Block

This newsletter signup form needs a storage option. Edit the block and enter a storage location via the Storage tab.

suscribe now

Email Address

Thank you!